CSL Limited (CSL)

CSL began as the Commonwealth Serum Laboratories, an Australian government agency dedicated to vaccine development, in 1916. It has operations in Australia, Germany, Switzerland, the United Kingdom, and the United States.

Biotherapies are developed and delivered by CSL. The company's main activities include biopharmaceutical and allied product research and development, manufacturing, marketing, and distribution. The company's headquarters are in Parkville, Victoria, with CSL Behring in King of Prussia, the USA, and Seqirus in Maidenhead.

CSL competes on the global stage as one of the largest and leading providers of in-licensed vaccines with its protein-based biotechnology businesses.

• Headquarters: Parkville, Melbourne, Victoria, Australia
• Founded: 1916
• Market cap: 139,81 Billion (11/2021)
• Website: www.csl.com